U 
Universal Health Services UHS · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
197.16
+0.85%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$17.36bn
FY2016FY2025
Net income
$1.49bn
FY2016FY2025
Free cash flow
$849.2m
FY2016FY2025
Shareholders' equity
$7.28bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36bn | $15.83bn | $14.28bn | $13.40bn | $12.64bn | $11.56bn | $11.38bn | $10.77bn | $10.41bn | $9.77bn |
| Gross profit | $15.71bn | $14.24bn | $12.75bn | $11.93bn | $11.21bn | $10.27bn | $10.13bn | $9.60bn | $9.30bn | $8.73bn |
| Operating income | $1.99bn | $1.68bn | $1.37bn | $1.13bn | $1.36bn | $1.36bn | $1.22bn | $1.18bn | $1.28bn | $1.28bn |
| Net income | $1.49bn | $1.14bn | $717.8m | $675.6m | $991.6m | $944.0m | $814.9m | $779.7m | $752.3m | $702.4m |
| Diluted earnings per share | 23.10 | 17.03 | 10.47 | 9.41 | 12.45 | 11.03 | 9.30 | 8.41 | 7.93 | 7.17 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.96bn | $14.47bn | $13.97bn | $13.49bn | $13.09bn | $13.48bn | $11.67bn | $11.27bn | $10.76bn | $10.32bn |
| Cash and short-term investments | $137.8m | $126.0m | $119.4m | $102.8m | $115.3m | $1.22bn | $61.3m | $105.2m | $74.4m | $33.7m |
| Total liabilities | $8.55bn | $7.71bn | $7.77bn | $7.52bn | $6.90bn | $7.07bn | $6.09bn | $5.80bn | $5.70bn | $5.71bn |
| Debt | $4.83bn | $4.50bn | $4.91bn | $4.81bn | $4.19bn | $3.86bn | $3.98bn | $4.00bn | $4.04bn | $4.14bn |
| Shareholders' equity | $7.28bn | $6.67bn | $6.15bn | $5.92bn | $6.09bn | $6.32bn | $5.50bn | $5.39bn | $4.99bn | $4.53bn |
| Shares outstanding | 64m | 67m | 69m | 72m | 80m | 86m | 88m | 93m | 95m | 98m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.86bn | $2.07bn | $1.27bn | $996.0m | $883.7m | $2.36bn | $1.44bn | $1.34bn | $1.18bn | $1.29bn |
| Capital spending | −$1.02bn | −$943.8m | −$743.1m | −$734.0m | −$855.7m | −$734.2m | −$663.5m | −$811.7m | −$609.4m | −$1.16bn |
| Free cash flow | $849.2m | $1.12bn | $524.7m | $262.0m | $28.0m | $1.63bn | $775.0m | $529.2m | $573.1m | $133.3m |
| Dividends paid | −$51.3m | −$53.3m | −$55.5m | −$58.4m | −$65.9m | −$17.3m | −$53.0m | −$37.3m | −$38.2m | −$38.9m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64bn | $4.50bn | $4.49bn | $4.50bn | $4.28bn | $4.10bn | $4.11bn | $3.96bn |
| Gross profit | $4.21bn | $4.07bn | $4.06bn | $4.08bn | $3.87bn | $3.70bn | $3.71bn | $3.57bn |
| Operating income | $516.7m | $502.9m | $622.7m | $521.7m | $500.3m | $454.8m | $472.5m | $384.2m |
| Net income | $358.4m | $348.7m | $445.9m | $373.0m | $353.2m | $316.7m | $332.4m | $258.7m |
| Diluted earnings per share | 5.98 | 5.82 | 6.92 | 5.79 | 5.48 | 4.91 | 4.96 | 3.86 |
| Cash from operations | $443.0m | $401.0m | $574.0m | $380.0m | $548.0m | $360.0m | $658.0m | $332.0m |
| Capital spending | −$227.0m | −$217.0m | −$281.0m | −$247.0m | −$266.0m | −$239.0m | −$245.0m | −$247.0m |
| Free cash flow | $216.0m | $184.0m | $293.0m | $133.0m | $282.0m | $121.0m | $413.0m | $85.0m |
| Total assets | $15.94bn | $15.68bn | $15.96bn | $15.34bn | $14.99bn | $14.88bn | $14.47bn | $14.35bn |
| Cash and short-term investments | $138.8m | $119.0m | $137.8m | $112.9m | $137.6m | $126.8m | $126.0m | $106.1m |
| Debt | $4.92bn | $4.78bn | $4.83bn | $4.76bn | $4.66bn | $4.73bn | $4.58bn | $4.73bn |
| Shareholders' equity | $7.51bn | $7.53bn | $7.28bn | $7.23bn | $7.03bn | $6.79bn | $6.67bn | $6.61bn |
Financial ratios
Data as of 1 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 90.4% | 90.0% | 89.3% | 89.0% | 88.7% | 88.9% |
| Operating margin | 11.5% | 10.6% | 9.6% | 8.4% | 10.8% | 11.8% |
| Net margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% |
| Return on equity | 20.5% | 17.1% | 11.7% | 11.4% | 16.3% | 14.9% |
| Return on assets | 9.3% | 7.9% | 5.1% | 5.0% | 7.6% | 7.0% |
| Free cash flow yield | 25.6% | 25.8% | 16.8% | 13.8% | 12.5% | 20.7% |
| Revenue growth | 9.7% | 10.8% | 6.6% | 6.0% | 9.4% | 1.6% |
| Earnings growth | 30.4% | 59.1% | 6.2% | -31.9% | 5.0% | 15.8% |
| Current ratio | 1.05x | 1.27x | 1.40x | 1.33x | 1.14x | 1.32x |
| Debt to equity | 0.66x | 0.69x | 0.81x | 0.82x | 0.70x | 0.62x |
| Equity ratio | 45.6% | 46.1% | 44.0% | 43.9% | 46.5% | 46.9% |
| Interest coverage | 12.68x | 8.97x | 6.62x | 8.88x | 15.99x | 12.45x |
| Buybacks as a share of market value | 3.9% | 2.2% | 4.5% | 9.9% | 6.9% | 2.3% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 9.0% | 8.5% | 6.7% |
| Operating income | 20.8% | 8.0% | 4.7% |
| Net income | 30.1% | 9.5% | 8.1% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 90.2% | 89.7% | 89.5% | 89.4% |
| Operating margin | 11.1% | 10.1% | 10.5% | 11.1% |
| Net margin | 7.9% | 6.6% | 7.0% | 7.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 9.4 | 10.5 | 14.6 | 15.0 | 10.4 | 12.5 | 15.4 | 13.9 | 14.3 | 14.8 |
| Price to sales | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 1.0 | 1.1 | 1.0 | 1.0 | 1.1 |
Market value over time
31 Oct 2016 to 30 Sept 2026, in USD
$11.87bn$10.45bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 27% | 18% | 12% | 8% | -8% | -6% | 25% | 2% | 6% | -10% |
Dividends and splits
Per share, in the currency the company pays
Paid for 23 years. Last went ex-dividend on 1 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.60 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.20 | 0.60 |
- 2-for-1 split · 16 Dec 2009
- 2-for-1 split · 4 Jun 2001
- 2-for-1 split · 20 May 1996
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.